CORONA Remedies Limited — Board Meeting, 31-07-2026: Outcome of Board Meeting
31-07-2026 | 05:32 pm
31-07-2026 | 05:32 pm
CORONA Remedies' Board meeting reviewed the Q1FY27 financial results. The company posted strong growth with revenue up 21.9% to ₹422.4 Cr and PAT rising 30.1% to ₹60.1 Cr. They also inaugurated a new Female Hormone Manufacturing Facility.
No comments yet. Be the first to comment!
